DEXTROSE AND SODIUM CHLORIDE INJ. Key specifications include primary_container_type: BOTTLE, protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 1000.000 MILLILITERS, active_medicament_medicinal_strength: 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT. This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-00-116-4600, indicating validated use in U.S.
government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.
| primary_container_type | BOTTLE |
| protective_storage_feature | SUBJECT TO DAMAGE BY FREEZING |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 6 |
| primary_container_content_quantity | 1000.000 MILLILITERS |
| active_medicament_medicinal_strength | 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | DEXTROSE INJECTION USP 5% 1000 ML BOTTLE 6 BOTTLES PER BOX |
| NSN | 6505-00-116-4600 |
| TOTAL PRIMARY CONTAINER QUANTITY | 6 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | DEXTROSE INJECTION USP 5% 1000 ML BOTTLE 6 BOTTLES PER BOX |
| PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 MILLILITERS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
| PRIMARY CONTAINER TYPE | BOTTLE, GLASS |